Bioinformatics-driven design and protective efficacy assessment of a multi-epitope vaccine for Toxoplasma gondii

Wenyong Feng, Lu Sun, Chenglong Yang, Jie Cao, Yongzhi Zhou, Jinlin Zhou, Longzheng Yu, Houshuang Zhang · 2026

Read Bioinformatics-driven design and protective efficacy assessment of a multi-epitope vaccine for Toxoplasma gondii by Wenyong Feng, Lu Sun, Chenglong Yang, Jie Cao, Yongzhi Zhou, Jinlin Zhou, Longzheng Yu, Houshuang Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13472923.txt.

Description

Feng and colleagues designed in 2026 a multi-epitope vaccine against Toxoplasma gondii, a parasite infecting about a third of humanity. The team picked six of its proteins from different life stages and predicted immune-triggering fragments, called epitopes, with computer tools. The chosen fragments were assembled into one designed molecule, checked for safety traits, and tested as a DNA vaccine in mice.

The design carried forty-one epitopes in total and docked strongly, in simulation, with an immune receptor. In mice, vaccination raised a key immune signal in blood compared with controls. Immune cell growth responses were also stronger in the vaccinated group. After challenge, treated mice survived far longer, while all control mice died within two to four days. The authors present the design pipeline as a template for vaccines of this kind.

Catalog record

CREATORWenyong Feng, Lu Sun, Chenglong Yang, Jie Cao, Yongzhi Zhou, Jinlin Zhou, Longzheng Yu, Houshuang Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13472923

Browse the full library · About the Tower of Babel